Plain-English translation of NCT07275333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a way to screen for cervical cancer using self-collected samples that women can take at home. The screening looks for a virus called HPV (human papillomavirus) that can lead to cervical cancer if left untreated. The goal is to make screening easier and safer for women in Ukraine during the ongoing conflict, using proven methods from Sweden adapted for local conditions.
Cervical cancer screening programs save lives, but the war in Ukraine has made it hard for women to access these services. This trial exists to bring screening directly to women in affected areas, so they can protect their health even when traveling to clinics is difficult or unsafe.
You likely qualify if…
You likely don't qualify if…
You will receive a simple sampling kit (called a FLOQSwab) that you can use to collect a sample from yourself at home or at a clinic location. You send the sample to a laboratory that will test it for HPV. Your results will be shared securely, and if you test positive, the study team will help connect you with follow-up care according to medical guidelines.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Ukraine
Sponsor
Karolinska Institutet
Collaborators
Union for International Cancer Control, Zaporizhzhiya State Medical University
Enrollment target
~1,000 participants
Started
April 2025
Primary completion
August 2026
Age range
30 Years – 60 Years
Sex
Female only
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Laila Sara Arroyo Mühr, PhD
Karolinska Institutet
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.